Bio Green Med Solution Inc
BGMS
2 hedge funds and large institutions have $714K invested in Bio Green Med Solution Inc in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
42% less capital invested
Capital invested by funds: $1.23M → $714K (-$519K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$358K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$628K |
| 2 |
Goldman Sachs
New York
|
-$41K |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$35K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$13K |
BGMS Hedge Fund Activity: Q2 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q2 2016, worth a combined $714K — down 42% from $1.23M a quarter earlier.
Fund positioning in BGMS was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $358K. The largest seller was Sabby Management, exiting entirely with an estimated $628K sold.
- 2 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $714K of Bio Green Med Solution Inc stock for Q2 2016, down 42% quarter-over-quarter.
- 1 fund opened new Bio Green Med Solution Inc positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest Bio Green Med Solution Inc buyer in Q2 2016 was Renaissance Technologies, an estimated $358K added.
- The largest Bio Green Med Solution Inc seller in Q2 2016 was Sabby Management, an estimated $628K sold.
Based on aggregated 13F filings for Q2 2016.